Cephalexin Tablet, Film Coated
NDC Package 59651-784-01
Package Information
Cephalexin tablets is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a tablet, film coated delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 59651-784 and is authorized under FDA application ANDA218817.
Identification & Billing
- RxCUI: 197454 - cephalexin 500 MG Oral Tablet
- RxCUI: 309115 - cephalexin 250 MG Oral Tablet
- RxCUI: 309115 - cefalexin (as cefalexin monohydrate) 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59651 - Aurobindo Pharma Limited
- 59651-784 - Cephalexin
- 59651-784-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 59651-784 - Cephalexin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59651-784-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Cephalexin, a human prescription drug labeled by Aurobindo Pharma Limited. This tablet, film coated is formulated for oral use and contains cephalexin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on September 27, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Aurobindo Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59651078401. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.